Toronto Dominion Bank’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25
| Closed | -$278 | – | 1257 |
|
|
2024
Q1 | $278 | Sell |
25
-59
| -70% | -$656 | ﹤0.01% | 1096 |
|
|
2023
Q4 | $942 | Buy |
84
+19
| +29% | +$213 | ﹤0.01% | 1091 |
|
|
2023
Q3 | $488 | Sell |
65
-8
| -11% | -$60 | ﹤0.01% | 1280 |
|
|
2023
Q2 | $1K | Sell |
73
-25,327
| -100% | -$347K | ﹤0.01% | 1184 |
|
|
2023
Q1 | $204K | Buy |
+25,400
| New | +$204K | ﹤0.01% | 972 |
|
|
2022
Q3 | – | Sell |
-61
| Closed | – | – | 1317 |
|
|
2022
Q2 | $0 | Sell |
61
-10
| -14% | – | ﹤0.01% | 1500 |
|
|
2022
Q1 | $0 | Buy |
71
+17
| +31% | – | ﹤0.01% | 1591 |
|
|
2021
Q4 | $0 | Buy |
54
+31
| +135% | – | ﹤0.01% | 1644 |
|
|
2021
Q3 | $0 | Sell |
23
-32
| -58% | – | ﹤0.01% | 1393 |
|
|
2021
Q2 | $0 | Buy |
55
+40
| +267% | – | ﹤0.01% | 1393 |
|
|
2021
Q1 | $0 | Buy |
+15
| New | – | ﹤0.01% | 1447 |
|
|
2020
Q4 | – | Sell |
-78
| Closed | – | – | 1300 |
|
|
2020
Q3 | $0 | Buy |
+78
| New | – | ﹤0.01% | 1194 |
|
|
2020
Q2 | – | Sell |
-23
| Closed | – | – | 1189 |
|
|
2020
Q1 | $0 | Sell |
23
-319
| -93% | – | ﹤0.01% | 1166 |
|
|
2019
Q4 | $2K | Buy |
342
+210
| +159% | +$1.23K | ﹤0.01% | 1061 |
|
|
2019
Q3 | $0 | Sell |
132
-16
| -11% | – | ﹤0.01% | 1153 |
|
|
2019
Q2 | $0 | Buy |
148
+119
| +410% | – | ﹤0.01% | 1163 |
|
|
2019
Q1 | $0 | Buy |
29
+17
| +142% | – | ﹤0.01% | 1171 |
|
|
2018
Q4 | $0 | Sell |
12
-65
| -84% | – | ﹤0.01% | 1152 |
|
|
2018
Q3 | $1K | Buy |
77
+54
| +235% | +$701 | ﹤0.01% | 1027 |
|
|
2018
Q2 | $0 | Buy |
+23
| New | – | ﹤0.01% | 1138 |
|
|
2018
Q1 | – | Sell |
-57
| Closed | -$1K | – | 1040 |
|
|
2017
Q4 | $1K | Buy |
57
+51
| +850% | +$895 | ﹤0.01% | 985 |
|
|
2017
Q3 | $0 | Buy |
+6
| New | – | ﹤0.01% | 1004 |
|